Evidence map›Paper›PMID 34657332›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study.

Y Lytvyn, J R Georgakopoulos, A Mufti, A R Devani, M J Gooderham, V Jain, P Lansang, R Vender, V H Prajapati, J Yeung

Open access · bronzeAbstract readLetterMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?International journal of molecular sciences · 2022
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Y LytvynTemerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.ORCID https://orcid.org/0000-0003-1805-9994
J R GeorgakopoulosDivision of Dermatology, Department of Medicine, University of Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-6844-2724
A MuftiDivision of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
A R DevaniDermatology Research Institute, Calgary, AB, Canada.
M J GooderhamQueen's University, Kingston, ON, Canada.
V JainClinal Immunology and Allergy, McMaster University, Hamilton, ON, Canada.
P LansangDivision of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
R VenderDepartment of Dermatology, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0002-2624-2724
V H PrajapatiSkin Health & Wellness Centre, Calgary, AB, Canada.
J YeungDivision of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
University of Toronto · CADermatrials Research · CAProbity Medical Research · CAQueen's University · CASKiN Health · CASunnybrook Health Science Centre · CAUniversity of Calgary · CA

Funding

Canadian Association of Psoriasis Patients Studentship
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19PsoriasisAnti-Inflammatory Agents, Non-SteroidalHumansIncidencePrognosisRetrospective StudiesSARS-CoV-2Severity of Illness IndexThalidomideAnti-Inflammatory Agents, Non-SteroidalapremilastThalidomide

Identifiers

PMID34657332
PMCPMC8656447
OpenAlexW3205583092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.